Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01415258|
Recruitment Status : Completed
First Posted : August 11, 2011
Last Update Posted : May 16, 2012
The objective of this study is to uncover the prevalence of vulnerability among patients aged ≥ 70 coming to the medical oncology division of the Oscar Lambret Centre, according to the short screening test Vulnerable Elders Survey 13 (VES-13).
The objective is to better understand the value of routine screening of patients before the consultation, it was proposed as a secondary objective of this study to assess the correlation between the identification of the vulnerability in the screening test VES-13 and the identification made by the clinician during the consultation. The correlation between VES-13 and opinion of the clinician for three categories of patients (self - intermediate - fragile) will also be studied.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||209 participants|
|Official Title:||Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre|
|Study Start Date :||March 2011|
|Actual Primary Completion Date :||August 2011|
|Actual Study Completion Date :||April 2012|
- To assess the Vulnerable Elders Survey score (VES-13) [ Time Frame: Within 3 months after recruitment ]A patient is identified vulnerable if the score is ≥ 3
- To assess the correlation between the VES-13 score and the vulnerability judged by a clinical expert [ Time Frame: Within 3 months after recruitment ]A patient will be identified as vulnerable if he/she belongs to the "intermediate" or "frail" category. The Kappa coefficient of agreement will be used to correlate the VES-13 score and clinical observations.
- To measure the muscle strength using the grip strength test [ Time Frame: Within 3 months after recruitment ]Hand Dynamometer Range values : 0-90
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01415258
|Oscar Lambret Anti-Cancer Centre|
|Lille cedex, France, 59020|
|Principal Investigator:||Véronique SERVENT, MD||Oscar Lambret Anti-Cancer Centre|